Sentry Investment Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $47K | Hold |
214
| – | – | 0.03% | 410 |
|
|
2025
Q1 | $43K | Sell |
214
-64
| -23% | -$12.9K | 0.03% | 387 |
|
|
2024
Q4 | $91K | Sell |
278
-45
| -14% | -$14.7K | 0.04% | 317 |
|
|
2024
Q3 | $97K | Hold |
323
| – | – | 0.04% | 342 |
|
|
2024
Q2 | $106K | Sell |
323
-66
| -17% | -$21.7K | 0.05% | 309 |
|
|
2024
Q1 | $154K | Hold |
389
| – | – | 0.06% | 278 |
|
|
2023
Q4 | $137K | Sell |
389
-42
| -10% | -$14.8K | 0.06% | 286 |
|
|
2023
Q3 | $162K | Sell |
431
-76
| -15% | -$28.6K | 0.08% | 257 |
|
|
2023
Q2 | $194K | Buy |
507
+23
| +5% | +$8.8K | 0.07% | 273 |
|
|
2023
Q1 | $168K | Buy |
+484
| New | +$168K | 0.07% | 281 |
|
|
2022
Q4 | – | Sell |
-494
| Closed | -$122K | – | 540 |
|
|
2022
Q3 | $122K | Hold |
494
| – | – | 0.06% | 321 |
|
|
2022
Q2 | $149K | Sell |
494
-96
| -16% | -$29K | 0.07% | 283 |
|
|
2022
Q1 | $242K | Sell |
590
-99
| -14% | -$40.6K | 0.08% | 257 |
|
|
2021
Q4 | $323K | Hold |
689
| – | – | 0.08% | 240 |
|
|
2021
Q3 | $293K | Sell |
689
-101
| -13% | -$43K | 0.09% | 241 |
|
|
2021
Q2 | $284K | Hold |
790
| – | – | 0.07% | 266 |
|
|
2021
Q1 | $223K | Sell |
790
-19,059
| -96% | -$5.38M | 0.06% | 296 |
|
|
2020
Q4 | $5.62M | Sell |
19,849
-1,277
| -6% | -$362K | 0.28% | 90 |
|
|
2020
Q3 | $5.81M | Sell |
21,126
-2,051
| -9% | -$564K | 0.32% | 76 |
|
|
2020
Q2 | $5.27M | Buy |
+23,177
| New | +$5.27M | 0.32% | 77 |
|